Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine

Teerasit Techawiwattanaboon^{1

2}, Thomas Courant³, Livia Brunner³, Suwitra Sathean-Anan-Kun^{1

2}, Pratomporn Krangvichian^{2

4}, Nutta Iadsee^{2

4}, Yaowarin Nakornpakdee⁵, Noppadon Sangjun⁶, Pat Komanee⁶, Nicolas Collin³, Kiat Ruxrungtham², Kanitha Patarakul^{1

2}

Affiliations

¹ Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
² Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand.
³ Vaccine Formulation Institute, Plan-Les-Ouates, Switzerland.
⁴ Medical Microbiology, Interdisciplinary Program, Graduate School, Chulalongkorn University, Bangkok, Thailand.
⁵ Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
⁶ Laboratory Animal Section, Analysis Division, Armed Force Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.

PMID: 40901003
PMCID: PMC12400854
DOI: 10.3389/fcimb.2025.1656235

Published Erratum

Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine

Teerasit Techawiwattanaboon et al. Front Cell Infect Microbiol. 2025.

. 2025 Aug 18:15:1656235.

doi: 10.3389/fcimb.2025.1656235. eCollection 2025.

Authors

Affiliations

¹ Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
² Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand.
³ Vaccine Formulation Institute, Plan-Les-Ouates, Switzerland.
⁴ Medical Microbiology, Interdisciplinary Program, Graduate School, Chulalongkorn University, Bangkok, Thailand.
⁵ Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
⁶ Laboratory Animal Section, Analysis Division, Armed Force Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand.

PMID: 40901003
PMCID: PMC12400854
DOI: 10.3389/fcimb.2025.1656235

Abstract

[This corrects the article DOI: 10.3389/fcimb.2022.918629.].

Keywords: Leptospira; QS21 saponin; QuilA saponin; adjuvant formulation; immunoglobulin-like protein A; neutral liposome; squalene-in-water emulsion; subunit vaccine.

PubMed Disclaimer

Erratum for

Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Leptospira Immunoglobulin-Like Protein A Subunit Vaccine.
Techawiwattanaboon T, Courant T, Brunner L, Sathean-Anan-Kun S, Krangvichian P, Iadsee N, Nakornpakdee Y, Sangjun N, Komanee P, Collin N, Ruxrungtham K, Patarakul K. Techawiwattanaboon T, et al. Front Cell Infect Microbiol. 2022 Jun 16;12:918629. doi: 10.3389/fcimb.2022.918629. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35782116 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Frontiers Media SA
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine

Affiliations

Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources